Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $9.9 Million - $11.3 Million
-44,100 Reduced 27.95%
113,685 $28.4 Million
Q4 2023

Feb 12, 2024

SELL
$185.1 - $233.13 $3.2 Million - $4.03 Million
-17,300 Reduced 9.88%
157,785 $36.5 Million
Q3 2023

Oct 27, 2023

BUY
$233.08 - $265.59 $699,240 - $796,769
3,000 Added 1.74%
175,085 $43.4 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $38.7 Million - $44.1 Million
172,085 New
172,085 $41.3 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Eagle Health Investments LP Portfolio

Follow Eagle Health Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.